The COC Protocol

Protocol Benefits

Multiple studies have shown the efficiency of a person’s metabolism may be a crucial factor in their cancer outcome. The COC Protocol is a metabolic cancer therapy that can be added to your standard-of-care treatments and is intended to:

  • Help improve your response to standard-of-care therapies (chemotherapy, immunotherapy, hormonal, and radiotherapies)
  • Reduce side effects from standard-of-care treatment.
  • Enable a process called apoptosis, or “programmed cell death,” of cancer cells
  • Return your body back to a healthy metabolic and inflammatory state following cancer treatment to help minimize recurrence.

Program Features

Results You Can Measure: While you’re enrolled in the program you’ll be able to visualize your progress through our new interactive digital platform (COC Health Insights) that shows you what you are doing well, where you’re at risk and what you need to improve.

Guided by Oncologists: Our program is delivered with oversight from experienced Metabolic Oncologists who can prescribe medications and other interventions to help improve your metabolic health.

Comprehensive Biomarker Testing: These tests look for specific metabolic and inflammatory markers that, if improved over time, lead to better health outcomes.

An In-Depth Health Report: A dynamic report informs you on your risk factors for cancer progression or recurrence based on your metabolic and immunologic functions. Quarterly check-ins will help us monitor and track your progress.

Protocol Medications: Care Oncology has patented protocol which uses medications designed to target the specific energy requirements of cancer cells, disrupting their ability to grow and multiply.

Lifestyle Recommendations: Your Care Oncology oncologist will make lifestyle recommendations (diet, sleep, stress, exercise) to help improve your biomarkers and overall health.

Now Featuring an Interactive Digital Health Platform, COC Health Insights!

The History of The COC Protocol

Obesity, Diabetes, Chronic Inflammation and Insulin Resistance are known risk factors for the development of many cancers. Therefore, cancer patients at diagnosis may be at greater risk of already having or developing Metabolic Syndrome

Our Research in Glioblastoma

What medications are included in the COC Protocol?

Below are some the medications we prescribe based on your individual cancer and health profile. Used in combination, these medications may help improve patients’ metabolic and inflammatory health in addition to lifestyle interventions.

Metformin: Along with ‘metabolically reprogramming’ cancer cells to make them potentially more vulnerable to standard of care treatments, metformin may also help to sensitize tumor response to standard therapies by: targeting generally harder to treat cancer stem cells, improving the hypoxic (low-oxygen) state which can often develop around tumors and which hinders the effectiveness of standard treatments, reversing multidrug resistance in cancer cells, and by beneficially modulating the tumor microenvironment (Tang et al, 2021, Jin et al, 2020).

Statins can improve the radiation sensitivity of cancer cells grown in the lab by increasing production of cell-damaging oxidative stress molecules (Hosseinimehr et al., 2020). Lab studies also show that statins can help reduce chemotherapy resistance in various different cancer cell types by targeting molecular processes in these cells- including blocking HMG-CoA reductase-dependent molecular pathways (Chen et al 2013, Chen et al, 2012).

Mebendazole may help to sensitize cancer cells to radiation therapy by increasing radiation-induced DNA damage. The drug can also work alongside chemotherapy drugs, overcoming cancer cell resistance (Guerini et al, 2019).

Doxycycline can help sensitize cancer cells to radiation by decreasing levels of a cell molecule called DNA-PK. Cancer cells are known to need this molecule for DNA repair, and it has been linked to radiation resistance in cancer cells (Lamb et al, 2015). Similar to metformin, doxycycline may also target cancer stem cells in low-oxygen areas that are resistant to traditional chemotherapies, and disrupt the molecular mechanisms that cancer cells use to produce energy (Tan et al, 2017 and De Francesco et al, 2017).

History of the COC Protocol

COC Protocol was developed by London-Based Care Oncology Clinic (COC) in 2013 and is based upon the work of German scientist Otto Warburg, who received a Nobel prize for his research on the unique cellular biology of cancer cell metabolism.

The COC Protocol is an individualized therapeutic approach to help lower the overall metabolic rate of cancer cells by simultaneously targeting multiple cancer pathways. This is accomplished through a specific combination of conventional pharmaceuticals which may work together to restrict the overall ability of cancer cells to take up and use (i.e., ‘metabolize’) energy.

Our New Program:

  • Measures and tracks fundamental parameters, which if optimized, may improve cancer outcomes, and mitigate risks from treatment related toxicities. We evaluate these specific parameters via blood tests (biomarkers) and questionnaires, enabling provision of actionable insights to our patients based on their personalized scores.
  • COC doctors carefully review patient data and make personalized, evidence-based recommendations to help drive improvements. This can include advice around diet and nutrition, stress, sleep, exercise, as well as the recommendation or prescription of a specific set of supplements with an excellent evidence-base in the cancer setting.
  • In addition, the COC blood test data enables our clinical team to objectively assess the degree of metabolic control which may be being exercised by COC Protocol pharmaceuticals and to further refine the dosing of these over time.